Los Angeles, CA, November 27, 2018 –(PRWirePro.com)– Medifocus, Inc. (OTCQB:MDFZF) and (TSX-V:MFS) (“Medifocus” or the “Company”), a biotechnology company with a portfolio of medical products encompassing thermotherapy systems for the treatment of Benign Prostatic Hyperplasia (BPH) and Breast Cancer, reported a 26% increase in revenue for the quarter ending September 30, 2018, and a 14% increase for the six months ending September 30, 2018, compared to the same periods in 2017.
New Haven, CT, November 20, 2018 –(PRWirePro.com)– Arvinas Inc. (Nasdaq:ARVN), a biotechnology company creating a new class of drugs based on protein degradation, today announced that John G. Houston, Ph.D., President and Chief Executive Officer, will participate in a fireside chat at the 30th Annual Piper Jaffray Healthcare Conference on Tuesday, November 27 at 8:00 a.m. ET in New York City. A live audio webcast of the presentation will be available at www.arvinas.com on the Events page. A replay of the webcast will be archived on the Arvinas website for 30 days following the presentation.
Shanghai, China, November 20, 2018 –(PRWirePro.com)– Pinduoduo Inc. (“Pinduoduo” or the “Company”) (NASDAQ:PDD), an innovative and fast growing “new e-commerce” platform and one of the leading Chinese e-commerce players, today announced its unaudited financial results for the third quarter ended September 30, 2018.